PTC THERAPEUTICS, INC.

Develops and commercializes pioneering medicines for patients with rare diseases.

PTCT | US

Overview

Corporate Details

ISIN(s):: US69366J2006
LEI:
Country:: United States of America
Address:: 500 WARREN CORPORATE CENTER DRIVE, 7059 WARREN
Website:: https://www.ptcbio.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PTC Therapeutics, Inc. is a global biopharmaceutical company that discovers, develops, and commercializes clinically differentiated medicines for children and adults with rare diseases and high unmet medical needs. The company's research focuses on innovative platforms, including splicing modulation and targeting inflammation and ferroptosis pathways for central nervous system diseases. PTC has brought several pioneering therapies to market, including the world's first approved treatment for Duchenne muscular dystrophy, the first gene therapy directly infused into the brain, and the first approved small molecule splicing modifier. The company leverages its ability to identify new therapies and globally commercialize products to invest in a diversified clinical pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PTC THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PTC THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for PTC THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
HWAIL PHARM. CO., LTD Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.	South Korea	061250
Hyloris Pharmaceuticals SA A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.	Belgium	HYL
HYUNDAI BIOLAND Co.,Ltd. Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.	South Korea	052260
Icure Pharmaceutical Incorporation Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.	South Korea	175250
Idorsia Ltd Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.	Switzerland	IDIA
IGC Pharma, Inc. Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.	United States of America	IGC
IL DONG PHARMACEUTICAL CO., LTD. Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.	South Korea	249420
ILSUNG IS CO., LTD. Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.	South Korea	003120
ILYANG PHARMACEUTICAL CO.,LTD Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.	South Korea	007570
I-Mab A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.	United States of America	IMAB